NorthWest Biotherapeutics Inc (NWBO)

[hyperopia]

True . . . until it’s not.

2018 ASM:

Will NWBO unblind data prior to ASCO?

Answer (LP): "ASCO is certainly a great venue, and it's been great for us when the timing has worked out, to be able to, as we did last year we had just announced the first interim data from our phase III trial, three days before ASCO, that just happened to work out beautifully on the timing. And a few years before that we had unveiled our initial DC Vax-Direct data. So we agree with you that its great when that works.
(transcript courtesy of Ike Feb 2, 2019)

Just sayin the timing works out nearly perfectly.